‘Absolute robbery’: Gilead announces $3,120 price tag for Covid-19 drug developed with $70 million...
“Taxpayers provided funding for the development of this drug. Now Gilead is price-gouging off it during a pandemic. Beyond disgusting,” said Sen. Bernie Sanders.
Millions exposed to toxic PFAS levels as EPA retreats from safety rules
New data reveals over 73 million Americans may be drinking water contaminated with toxic PFAS, while the EPA under Trump moves to weaken or repeal health standards.
After visiting Standing Rock, Swedish bank puts companies behind DAPL on watch
“It is becoming increasingly clear that financial institutions view the Dakota Access pipeline as a liability.”
Exposed: how Pfizer exploits secretive vaccine contracts to strong-arm governments
“Pfizer has used its monopoly on a lifesaving vaccine to extract concessions from desperate governments,” said the report’s author, urging action from the Biden administration.
Meatless Companies Band Together to Counter the Big Food Lobby
The Plant Based Foods Association is the first trade group to represent the growing sector.
The USPS is the only organization that was forced to pre-pay for health benefits...
“The Postal Service's $15 billion debt is a direct result of the mandate.”
Promising coronavirus treatment granted exclusive status to Gilead Sciences by FDA
"We will not tolerate profiteering. Any treatment or vaccine must be made free for all."
Selling insurance across state lines
Experts cited several reasons that the across-state-lines idea wouldn’t be a cure for high premiums as the president implied.
Millions consumed potentially unsafe water in the past 10 years
The American Society of Civil Engineers gave the U.S. a “D” grade for the quality of its drinking water systems based on an evaluation of their safety, condition, capacity and other criteria.
Wasted lives: The worldwide tragedy of youth suicide
Principles of goodness together with the golden seed of social justice – sharing – need to be the guiding ideals of a radically redesigned socio-economic paradigm.